| Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases S Abu-Rumeileh, A Abdelhak, M Foschi, H Tumani, M Otto Journal of neurology 268 (4), 1133-1170, 2021 | 542 | 2021 |
| Blood GFAP as an emerging biomarker in brain and spinal cord disorders A Abdelhak, M Foschi, S Abu-Rumeileh, JK Yue, L D’Anna, A Huss, ... Nature Reviews Neurology 18 (3), 158-172, 2022 | 478 | 2022 |
| Serum GFAP as a biomarker for disease severity in multiple sclerosis A Abdelhak, A Huss, J Kassubek, H Tumani, M Otto Scientific reports 8 (1), 14798, 2018 | 248 | 2018 |
| Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker? A Abdelhak, T Hottenrott, E Morenas-Rodríguez, M Suárez-Calvet, ... Frontiers in neurology 10, 280, 2019 | 130 | 2019 |
| Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis S Meier, EAJ Willemse, S Schaedelin, J Oechtering, J Lorscheider, ... JAMA neurology 80 (3), 287-297, 2023 | 117 | 2023 |
| Neurofilaments as biomarkers in neurological disorders—towards clinical application M Khalil, CE Teunissen, S Lehmann, M Otto, F Piehl, T Ziemssen, ... Nature Reviews Neurology 20 (5), 269-287, 2024 | 86 | 2024 |
| The multifaceted role of neurofilament light chain protein in non-primary neurological diseases S Abu-Rumeileh, A Abdelhak, M Foschi, L D'Anna, M Russo, P Steinacker, ... Brain 146 (2), 421-437, 2023 | 73 | 2023 |
| MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature S Jarius, K Ruprecht, JP Stellmann, A Huss, I Ayzenberg, A Willing, ... Journal of Neuroinflammation 15, 1-5, 2018 | 68 | 2018 |
| Primary progressive multiple sclerosis: putting together the puzzle A Abdelhak, MS Weber, H Tumani Frontiers in neurology 8, 234, 2017 | 66 | 2017 |
| CSF profile in primary progressive multiple sclerosis: Re-exploring the basics A Abdelhak, T Hottenrott, C Mayer, G Hintereder, UK Zettl, O Stich, ... PLoS One 12 (8), e0182647, 2017 | 50 | 2017 |
| A score based on NfL and glial markers may differentiate between relapsing–remitting and progressive MS course A Huss, M Otto, M Senel, AC Ludolph, A Abdelhak, H Tumani Frontiers in Neurology 11, 608, 2020 | 46 | 2020 |
| Neurofilament light chain elevation and disability progression in multiple sclerosis A Abdelhak, P Benkert, S Schaedelin, WJ Boscardin, C Cordano, ... JAMA neurology 80 (12), 1317-1325, 2023 | 35 | 2023 |
| Intrathecal immunoglobulin M production: a promising high‐risk marker in clinically isolated syndrome patients A Huss, A Abdelhak, S Halbgebauer, B Mayer, M Senel, M Otto, H Tumani Annals of neurology 83 (5), 1032-1036, 2018 | 34 | 2018 |
| Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer … CL Kemmerer, V Pernpeintner, C Ruschil, A Abdelhak, M Scholl, ... PLoS One 15 (7), e0235449, 2020 | 30 | 2020 |
| In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis A Abdelhak, A Huebers, K Boehm, AC Ludolph, J Kassubek, ... Journal of neurology 265, 949-953, 2018 | 29 | 2018 |
| Brain-specific cytoskeletal damage markers in cerebrospinal fluid: is there a common pattern between amyotrophic lateral sclerosis and primary progressive multiple sclerosis? A Abdelhak, A Junker, J Brettschneider, J Kassubek, AC Ludolph, M Otto, ... International journal of molecular sciences 16 (8), 17565-17588, 2015 | 28 | 2015 |
| Longitudinal serum neurofilament levels of multiple sclerosis patients before and after treatment with first-line immunomodulatory therapies A Huss, M Senel, A Abdelhak, B Mayer, J Kassubek, AC Ludolph, M Otto, ... Biomedicines 8 (9), 312, 2020 | 26 | 2020 |
| An autoantibody signature predictive for multiple sclerosis CR Zamecnik, GM Sowa, A Abdelhak, R Dandekar, RD Bair, KJ Wade, ... Nature Medicine 30 (5), 1300-1308, 2024 | 24 | 2024 |
| Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual … A Abdelhak, L Barba, M Romoli, P Benkert, F Conversi, L D’Anna, ... Journal of neurology 270 (7), 3315-3328, 2023 | 23 | 2023 |
| Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study A Abdelhak, F Petermeier, P Benkert, S Schädelin, J Oechtering, ... The Lancet Neurology 22 (9), 826-833, 2023 | 22 | 2023 |
Samir Abu RumeilehDepartment of Neurology, Martin-Luther-University of Halle-Wittenberg, Halle (Saale), GermanyCorreu electrònic verificat a uk-halle.de